Chocolate Reformulation in 2026: How US Food Policy Reshapes NPD

Roughly 18% of US adults were using a GLP-1 medication in spring 2026, up from 14% a year earlier, according to FTI Consulting survey data. Separately, HHS reports that "nearly 60% of the American diet is made up of ultra-processed foods", the framing driving the August 2026 policy announcements. Both figures are moving faster than most brand roadmaps were built to accommodate.

Table of contents:

• Where US Food Policy Is Moving in 2026 — Four Shifts That Reach the NPD Brief

• The New "Healthy" Claim, Front-of-Pack Labelling, and What They Change for Chocolate

• Ultra-Processed Foods, State Legislation, and the Fragmented Compliance Map

• GLP-1 Adoption and the Shift Toward High-Protein, Portion-Controlled Formats

• Where Ingredient Choices Meet the Policy Moment: Reformulation Levers for Chocolate Brands

• FAQs

Where US Food Policy Is Moving in 2026

None of these shifts are speculative. Each has a rule, a proposed rule, or a measurable market signal already attached. What they share is a common consequence for chocolate product development: the criteria by which a product is judged, labelled and chosen are being rewritten at roughly the same time.

The four shifts, in the order they hit the NPD conversation:

• The updated FDA definition of "healthy" (final rule, effective February 2025; mandatory compliance February 2028) — the first time added sugar is a disqualifying nutrient for that claim.
• A proposed front-of-package "Nutrition Info Box" (published January 2025, still in FDA review as a 2026 priority deliverable) that would rank added sugar, saturated fat and sodium as Low, Medium or High.
• A federal proposed definition of "ultra-processed foods" (submitted August 2026 by HHS and USDA), running in parallel with state-level UPF laws already passed or in draft.
• Ongoing GLP-1 adoption reshaping what consumers actually buy — with published survey data pointing to roughly one in six US adults on a medication as of spring 2026.

Each is covered in the sections that follow, along with what it changes for a chocolate brief specifically.

The New "Healthy" Claim, Front-of-Pack Labelling and What They Change for Chocolate

For the first time in three decades, the FDA has redefined what "healthy" means on a food label. The final rule was published in December 2024 and became effective on 25 February 2025. Mandatory compliance for brands using the claim is 25 February 2028, with voluntary use of the new definition permitted from 28 April 2025.

Two changes matter for chocolate. First, the rule adds a limit on added sugar — a product carrying the "healthy" claim can no longer exceed a defined threshold of added sugars per serving. Second, the rule now requires products to contribute meaningfully to at least one recognised food group before they can qualify. Most conventional chocolate products won't clear either bar in their current formulation.

Running alongside this is FDA's proposed front-of-package "Nutrition Info Box", published for comment in January 2025 and listed as a 2026 priority deliverable. The proposed label would rank three nutrients — added sugar, saturated fat and sodium — as Low, Medium or High relative to the Daily Value, based on a black-and-white system that outperformed colour-coded alternatives in FDA's own consumer testing. It's not yet finalised. Once it is, brands with annual food sales above $10 million would have three years to comply.

For a chocolate brand, the practical implication of both rules is convergent: added sugar becomes visibly, unavoidably part of the front-of-pack conversation. A product that quietly disclosed sugar content in the Nutrition Facts panel on the back will now flag it on the front — with a three-tier judgement attached.

Key Insight: Reformulation for the "healthy" claim and reformulation for a favourable front-of-pack score aren't the same brief. The "healthy" claim is opt-in and demands food-group contribution alongside sugar reduction. The front-of-pack ranking is mandatory (once finalised) and looks only at nutrient levels. A product can score well on one and not the other.

Actionable Tip: When scoping a reformulation, model both scenarios in parallel. A recipe that clears the added-sugar threshold for "healthy" but still lands "High" on saturated fat won't get the marketing benefit brands typically expect from the sugar work alone.

Ultra-Processed Foods, State Legislation and the Fragmented Compliance Map

The federal picture on ultra-processed foods (UPFs) shifted in August 2026, when HHS and USDA submitted for final review the first proposed federal definition of UPFs. In the same announcement, HHS proposed a rule requiring manufacturers to notify FDA whenever they conclude that a substance added to food is "Generally Recognised as Safe" (GRAS) — reducing the scope for self-affirmed GRAS determinations that don't reach the agency's public inventory.

Neither is finalised, and neither has an enforcement date. Both are significant for chocolate because both change what has to be disclosed and how a product's ingredient profile is likely to be judged in downstream retailer and consumer settings.

The state picture is moving faster. In 2025, California signed the first US state law defining ultra-processed foods and beginning to phase them out of school food programmes. KFF Health News reports that legislators in Texas, Florida, West Virginia and others are drafting or evaluating similar measures for 2026 sessions. State attorneys general and city-level actions add another layer — San Francisco's city attorney filed a lawsuit in late 2025 naming specific branded cereals, pizzas, sodas and chips as "harmful and addictive."

The historical parallel worth naming: menu labelling followed a similar trajectory. Before the federal rule took effect in 2018, more than 20 different state and local calorie-labelling laws were in force, each with its own thresholds, formats and disclosure rules. Brands operating across multiple states had to reconcile them until federal preemption arrived. UPF regulation looks likely to run through the same fragmentation phase — a state-by-state period before any federal standard becomes the reference point.

Key Insight: For chocolate brands selling into multiple US states, the near-term risk isn't that the federal UPF definition arrives in a form that catches their portfolio. It's that state-level definitions arrive earlier, and don't line up with each other or with what the federal rule eventually says.

Actionable Tip: When mapping distribution, track which states have enacted, proposed or introduced UPF-related legislation, and cross-check against the states where the brand's SKUs are sold into schools, hospitals or state-procured food programmes. Those are the channels where a state UPF classification bites first.

GLP-1 Adoption and the Shift Toward High-Protein, Portion-Controlled Formats

GLP-1 medications aren't a regulation. They're a market force operating at regulatory scale.

Roughly 18% of US adults were using a GLP-1 medication in spring 2026, up from around 14% in 2025, according to FTI Consulting's national survey. Adoption is highest in the 35–54 age group at 23%. FTI's estimate: as newer dosage forms improve, patent cliffs approach, and out-of-pocket costs fall, one in two eligible adults may adopt a GLP-1 over the next decade.

The mechanism is well-documented. GLP-1s suppress appetite and slow gastric emptying, and users report lower total calorie intake, smaller basket sizes, and greater selectivity at the grocery shelf. When intake drops, what remains needs to work harder — nutrient density per calorie becomes the shortcut most GLP-1 consumers report using.

The reformulation response is already underway. Nestlé launched its first new brand in nearly 30 years explicitly for GLP-1 consumers. General Mills and Danone have moved portfolio positioning toward high-fibre, high-protein, satiety-forward formats. Ingredient demand has followed — whey protein, milk proteins and functional fibres are the categories reporting the fastest reformulation-driven pull.

For chocolate specifically, three consumer patterns are worth attending to:

• Smaller portions. GLP-1 users report skipping full-size confectionery in favour of single-portion or reduced-format products.
• Protein positioning. Products that combine chocolate with functional protein levels increasingly compete against non-chocolate snack formats for the same occasion.
• Sugar sensitivity. GLP-1 users report reduced tolerance for high-sugar products, both physically and by preference — collapsing the historical assumption that indulgence categories are immune to sugar-reduction pressure.

Key Insight: GLP-1 adoption doesn't shrink the chocolate category — it re-sorts it. Products designed for the pre-GLP-1 basket (large formats, high sugar per serving, low protein) lose share to products designed for the new one, within the same category.

Where US Food Policy Influences the Chocolate NPD Brief 

Where Ingredient Choices Meet the Policy Moment: Reformulation Levers for Chocolate Brands

The reformulation question isn't whether to respond, but which levers to reach for first. Three come up repeatedly in briefs shaped by the four shifts above.

Allulose. A rare sugar that behaves like sucrose in bulk, browning, and freeze-point depression, at roughly 0.4 kcal/g. Under FDA guidance issued in 2020 and reaffirmed in updated draft guidance in late 2025, allulose is excluded from Total Sugars and Added Sugars declarations on the Nutrition Facts panel, though it still counts in Total Carbohydrates. For a chocolate reformulation aiming at the "healthy" claim's added-sugar threshold, or at a favourable front-of-pack score, allulose is one of the few tools that keeps the sugar-like functional profile intact.

No-added-sugar formulations. These sit on stricter ground than "sugar-free" and speak more directly to consumers reading Nutrition Facts panels for added sugar specifically — the metric both the new "healthy" claim and the proposed front-of-pack label centre on. A no-added-sugar chocolate that still delivers on flavour and mouthfeel is a different technical brief from a reduced-sugar one, and typically depends on the sweetener system rather than sugar removal alone.

Functional protein (whey). The pattern of ingredient demand pulled by GLP-1 reformulation — whey, milk protein, functional fibre — puts protein-enriched chocolate in a new category context. Luker's protein chocolate delivers 5g of protein per 30g serving, positioned as a way to boost the protein content of a finished product rather than as a standalone protein claim. Chocolate carrying meaningful protein content competes against protein bars and functional snacks for the same GLP-1-user occasion, and can support the food-group contribution requirement in the new "healthy" claim through its dairy content.

None of these is a single-shift answer. Allulose supports the "healthy" claim and front-of-pack rankings but doesn't address UPF classification. Functional protein supports GLP-1-driven demand and food-group requirements but adds ingredient complexity that may pull the product in the other direction on UPF scoring. The reformulation brief now involves trading between four constraint systems, not one — which is where the R&D and regulatory conversation belongs earlier, not after formulation is done.

FAQs

When does the new FDA "healthy" claim become mandatory?

The final rule took effect on 25 February 2025, with voluntary use of the new definition permitted from 28 April 2025. Mandatory compliance for products bearing the "healthy" claim is 25 February 2028.

Is the front-of-pack "Nutrition Info Box" a done deal?

Not yet. FDA published the proposed rule in January 2025 and listed it as a 2026 priority deliverable. As of mid-2026, the agency was still processing public comments. Once finalised, large companies would have three years to comply; smaller businesses would get four.

Does the federal UPF definition apply to products yet?

No. HHS and USDA submitted the proposed definition for final review in August 2026. It hasn't been finalised, and no enforcement or classification mechanism has been attached. State-level UPF definitions — starting with California's 2025 law — are enforceable within their own jurisdictions independently of the federal timeline.

Does allulose count as added sugar on US Nutrition Facts panels?

FDA's enforcement position, restated in draft guidance in late 2025, is that manufacturers may exclude allulose from Total Sugars and Added Sugars declarations, while still counting it in Total Carbohydrates. That position is exercised as enforcement discretion rather than a formal rule change.

How large is the GLP-1 consumer base influencing food purchasing?

Roughly 18% of US adults were using a GLP-1 medication in spring 2026, up from around 14% in 2025, according to FTI Consulting. Adoption is highest in the 35–54 age group. Multiple food manufacturers have publicly stated the effect on their category sales is expected to be structural rather than transient.

Do these US food policy changes apply to imported chocolate?

Yes. FDA labelling rules apply to products sold in US commerce regardless of country of manufacture. State UPF and school-procurement laws apply to products sold within the relevant jurisdiction. A brand exporting to the US operates under the same US label and claim regime as a domestic brand.

Key takeaway: The 2026 US policy landscape doesn't ask chocolate NPD teams to make one choice. It asks them to make several at once, against criteria that are still being finalised in parallel. The brands that come through the next 18 months in the strongest position are the ones treating "healthy" claim readiness, front-of-pack scoring, UPF classification exposure and GLP-1-shaped demand as a single strategic map, not as four separate briefs handed to R&D one at a time.

Related resources:

Sugar Chocolate Claims: USA vs UK Labelling Map

5 Key Variables for Strategic Chocolate Decisions

Balance | Better-For-You Chocolate Formulations

Sources:

FDA, Food Labeling: Nutrient Content Claims; Definition of Term "Healthy" (final rule, February 2025)

FDA, Front-of-Package Nutrition Labeling proposed rule (January 2025)

HHS, Landmark Food Policy Reforms Under MAHA Agenda (August 2026)

KFF Health News, MAHA in Statehouses: What to Expect in 2026 (April 2026)

FTI Consulting, GLP-1 Drugs Are Rewriting the Rules of Food (July 2026)

Tastewise, GLP-1 Food Industry Impact In The US: 2026 CPG Playbook (April 2026)

IngExchange / American International Foods, How GLP-1s Are Affecting the Food Industry (August 2026)

EveryBite, 2026: The Year Allergen Laws Come for Restaurants (January 2026)

Nutritional Outlook, FDA on allulose exclusion from sugar declarations (December 2025)

Icon Foods, Allulose Outlook Q4-2025 to 2026 (August 2026)

Innova Market Insights, North American consumer demand for lower-sugar, protein-enriched chocolate (2024)